MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2018 International Congress

    Investigation of the incidences of non-motor symptoms in first-degree relatives and the spouses of patients with Parkinson’s disease

    J.B. Liu, X.J. Zhang, C.F. Liu (Yangzhou, China)

    Objective: The first-degree relatives of PD patients (such as siblings) and the spouses living together for many years do not have classic motor symptoms. However,…
  • 2018 International Congress

    The International Parkinson and Movement Disorder Society Non-Motor Scale (MDS-NMS) for Parkinson’s Disease: Preliminary results from an international validation

    K. Ray Chaudhuri, D. Weintraub, A. Rizos, A. Schrag, P. Martinez-Martin (London, United Kingdom)

    Objective: To provide an update on the ongoing international validation programme of an expanded, refined and improved scale for the assessment of non-motor symptoms (NMS)…
  • 2018 International Congress

    Factors associated with freezing of gait in patients with Parkinson’s disease

    S.M. Choi, J.M. Kim, J.K. Lee, S.H. Kim, M.H. Park, K.W. Kang, K.H. Choi, J.T. Kim, S.H. Lee, M.S. Park, B. Kim, M.K. Kim (Gwangju, Republic of Korea)

    Objective: The aim of this study was to estimate the prevalence of FOG (FOG), and to identify factors that independently contribute to FOG in patients…
  • 2018 International Congress

    Prevalence and relationship of non-motor symptoms of Parkinson’s disease with plasma uric levels

    Y. Zubair, S. Oyakhire, S. Abdulrahaman, O. Medu, S. Bwala (Abuja, Nigeria)

    Objective: To determine prevalence of non-motor symptoms (NMS) using the NMS Questionnaire (NMSQuest) and its relationship with plasma uric acid (UA) levels among Parkinson's Disease…
  • 2018 International Congress

    Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)

    V. Luk, N. Cheung, G. Chan, KF. Leung, NFJ. Lui, WW. Wong, I. Chan, C. Li (Kowloon, Hong Kong)

    Objective: This study aimed to translate and validate a standard Hong Kong Chinese version of the NMSQuest (HK-NMSQuest) to assist in identification of NMS in…
  • 2018 International Congress

    The Reliability Study of King’s Parkinson’s Disease Pain Scale in Indonesian Version

    V. Wijaya, R. Pinzon (Yogyakarta, Indonesia)

    Objective: To create the reliable Indonesian Version of King’s Parkinson’s Disease Pain Scale. Background: Pain is one of the most common non-motor symptoms of Parkinson’s…
  • 2018 International Congress

    Psychosocial Impact of dysarthria: Is speech intelligibility an effective measure outcome?

    C. Atkinson-Clement, A. Letanneux, M. Berthelot, D. Robert, C. Robieux, C. Moreau, G. Baille, A. Eusebio, F. Fluchère, E. Robin, T. Witjas, J.P. Azulay (Aix-en-Provence, France)

    Objective: To identify if intelligibility or social repercussions of dysarthria determined quality of life in patients with different kinds of movement disorders. Background: Dysarthria in…
  • 2018 International Congress

    Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson’s disease with motor fluctuation

    KW. Park, HS. Ryu, MS. Kim, NR. Choi, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the efficacy of levodopa/carbidopa/entacapone (Stalevo®) at bedtime on sleep disturbance in patients with Parkinson’s disease (PD) who have motor fluctuation. Background: Sleep…
  • 2018 International Congress

    Serum Uric Acid Level and Its Relationship to Non-Motor Symptomatology in Parkinson’s disease

    O. Odeniyi, N. Okubadejo, O. Ojo, M. Danesi (Lagos, Nigeria)

    Objective: To determine the relationship between serum uric acid level and non-motor symptoms using the PD specific non-motor symptoms in Nigerian patients with Parkinson’s disease.…
  • 2018 International Congress

    FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease

    R. Fuller, P. Feigenbaum, C. Fitzer-Attas, N. La Pelle, S. Luo, C. Sampaio, G. Stebbins (Princeton, NJ, USA)

    Objective: Develop a patient-reported outcome (PRO) modification of the Functional Rating Scale for pre-Huntington Disease (FuRST-pHD) using focus group, Delphi panel and cognitive pre-testing methodology.…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley